Prequel, a skincare line founded by dermatologist Dr. Sam Ellis in 2023, is gaining rapid traction by offering practical, science‑based products at prices most consumers can afford. The brand’s focus on education,ingredient quality, and low‑cost packaging has turned it into a favorite among shoppers tired of hype‑driven luxury brands.

Dr. Sam Ellis launches brand in 2023 with a "basic plus" mission

According to the source report, Ellis created Prequel to fill what she calls the "first chapter" of a user’s skincare routine, delivering a foundational set of products that can be layered with later treatments. the brand’s tagline emphasizes practicality over luxury, a stance that resonates with patients seeking reliable results without the premium price tag.

Prequel's sub‑$25 pricing strategy keeps products accessible

The article notes that most Prequel items are priced under $25, a deliberate choice that reflects the company’s commitment to invest in formulation rather than marketing spend. Bulk sourcing of ingredients and packaging has allowed the brand to maintain these low price points while still offering generous product sizes.

The 50% glycerin cleanser draws tester praise from The Strategist staff

The Strategist’s testing team highlighted the brand’s 50% glycerin cleanser as a standout, citing its ability to cleanse without stripping moisture. Reviewers also praised a hydrating lip gloss with SPF and a high‑strength AHA peel, underscoring the line’s focus on effective, everyday actives.

Partnership with The Center in Los Angeles fuels operational growth

As the source explains, Prequel’s collaboration with The Center in Los Angeles has supported its scaling efforts, providing logistical and distribution assistance that helped the brand meet rising demmand.

Unverified claim: long‑term efficacy of over‑the‑counter retinoid gel

While the report mentions an OTC retinoid gel in Prequel’s catalog, it does not provide independnet data on its long‑term safety or effectiveness, leaving consumers to rely on anecdotal feedback until clinical studies emerge.